CEO SUMMARY: In the absence of public discussion, continued use of the “free testing” strategy by the nation’s more aggressive laboratory companies could trigger some unpleasant consequences that would affect all laboratories and pathology group practices. Five questions, presented here, illustrate how private and public healthcare payers might react to the ongoing use of “free […]
Where Will “Free Tests” Take the Lab Industry?
Increased use of this marketing strategy could have serious financial consequences
- By Robert Michel
- > From the Volume X No. 16 - December 1, 2003 Issue
- Tags: billing medicare, cap, dark report, executive war college, impac, lab industry, lab sale, lab sales, lab test, lab testing, laboratories, laboratory companies, laboratory director, laboratory industry, laboratory test, laboratory testing, managed care, managed care plan, Medicare, pathologists, Pathology group, private payer, the dark report, the laboratory
